Your browser doesn't support javascript.
loading
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
McCulloch, Rory; Lewis, David; Crosbie, Nicola; Eyre, Toby A; Bolam, Simon; Arasaretnam, Anita; Creasey, Thomas; Goradia, Harshita; McMillan, Annabel; Dawi, Safia; Harrison, Samuel; Miles, Oliver; Robinson, Andrew; Dutton, David; Wilson, Matthew R; McKay, Pam; Follows, George; Phillips, Neil; Patmore, Russell; Lambert, Jonathan; Bishton, Mark; Osborne, Wendy; Johnston, Rosalynd; Kirkwood, Amy A; Rule, Simon.
Afiliação
  • McCulloch R; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Lewis D; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Crosbie N; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Bolam S; Taunton and Somerset NHS Foundation Trust, Taunton, United Kingdom.
  • Arasaretnam A; Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom.
  • Creasey T; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom.
  • Goradia H; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • McMillan A; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Dawi S; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Harrison S; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
  • Miles O; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, United Kingdom.
  • Robinson A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Dutton D; Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom.
  • Wilson MR; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Follows G; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Phillips N; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
  • Patmore R; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Lambert J; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Bishton M; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Osborne W; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom.
  • Johnston R; Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom.
  • Kirkwood AA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom.
  • Rule S; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom.
Br J Haematol ; 193(2): 290-298, 2021 04.
Article em En | MEDLINE | ID: mdl-33620106
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Linfoma de Célula do Manto / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Linfoma de Célula do Manto / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article